Neocis

Key People

• Alon Mozes - CEO & Co-Founder
• Juan Salcedo - Co-Founder & Engineering Fellow
• Andres Carrillo - VP, Product
• Joseph Pang - VP, Operations
• Matt Norwood - Vice President of Sales
• Gabe Goldberg - VP of Marketing
• Allison (Butler) Sorensen - Senior Director Of Human Resources

Assessment

Team

Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in medical robotics and product development.

Neocis' leadership includes co-founders with prior experience at MAKO Surgical, a pioneer in orthopedic robotics. This background provides a solid foundation for developing and commercializing advanced dental robotic systems.

Clinical Need

Aspect: Very Strong
Summary: The Yomi system addresses a significant need for precision and efficiency in dental implant surgeries.

Dental implant procedures require high precision to ensure successful outcomes. Yomi's robotic assistance offers real-time guidance, improving accuracy and potentially reducing complications, thereby fulfilling a strong clinical need.

Competition

Aspect: First mover
Summary: Neocis is the first to market with an FDA-cleared robotic system for dental surgery.

As the first company to receive FDA clearance for a dental surgical robot, Neocis has established itself as a leader in this niche market, setting the standard for future competitors.

Technical Challenge

Aspect: Predictable
Summary: The development of Yomi involves complex but manageable technical challenges.

While integrating robotics into dental surgery presents technical challenges, Neocis' team's prior experience in similar fields suggests a capacity to address and overcome these challenges effectively.

Patent

Aspect: Very Strong
Summary: Neocis holds multiple patents protecting its innovative technologies.

Holding multiple patents ensures that Neocis' proprietary technologies are legally protected, preventing competitors from easily replicating their innovations and maintaining a competitive advantage.

Financing

Aspect: Well-funded
Summary: Neocis has secured substantial funding from reputable investors.

With over $180 million in funding from investors like NVentures and Intuitive Ventures, Neocis is well-positioned financially to continue its growth trajectory and invest in further technological advancements.

Regulatory

Aspect: 510k/PMA
Summary: Yomi has received multiple FDA clearances, including for full-arch rehabilitation and bone reduction.

The FDA clearances validate the safety and efficacy of Yomi, enabling Neocis to market its product confidently and expand its user base among dental professionals.

Opportunity Rollup

Odds of Success

4

Peak Market Share

5.35

Segment CAGR

5.0%

Market Segment

Dental Devices

Market Sub Segment

Dental Robotics

Key Takeaway

Neocis, with its pioneering Yomi system, is well-positioned to capitalize on the growing demand for precision in dental implant surgeries, supported by a strong team, robust funding, and favorable industry trends.